Evaluating the Safety and Efficacy of Duloxetine in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis

Clinical trial NCT06860984 · RECRUITING

Trial details

NCT number: NCT06860984
Sponsor: Tanta University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Biliary Disease

Start date: 2025-03-10
Primary completion: 2027-06-20
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.